For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene [...]
T cells, a frontline element in our bodies’ defense against pathogenic invaders, rely on the T cell receptor (TCR) to recognize enemies. This cell surface [...]
KromaTiD and SeQure Dx enter partnership agreement to offer comprehensive, IND-enabling gene editing services supporting cell and gene therapy research Longmont, CO. and Waltham, [...]
Induced pluripotent stem cells (iPSCs) hold great value in research because of their unique ability to differentiate into various cell types. These cells offer a [...]
Gene editing technologies have revolutionized the field of molecular biology, offering powerful tools to modify DNA with precision. Two primary categories of gene editing methodologies [...]
The advent of CRISPR-Cas9 marked a turning point in the realm of genetics and molecular biology. The technology made gene editing more accessible, efficient, and [...]
Whether it be for clinical or research studies, peripheral blood (PB) is one of the most accessible human sample types. It serves as a window [...]
Fluorescence microscopy is a powerful tool used for many scientific and medical applications to gather data at the highest possible resolution. A vital part of [...]
Human chromosomes are intricate and dynamic structures. Along the length of a chromosome’s DNA are regions encoding proteins, sequences regulating gene expression, pieces of viral [...]
The field of cytogenetics has enabled deep insights into the structure and behavior of chromosomes and the DNA from which they are built. Cytogenetics methods [...]
